• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用肝胆期磁共振图像衍生的定量参数对具有高度侵袭性特征的肝细胞癌进行术前预测。

Preoperative prediction of hepatocellular carcinoma with highly aggressive characteristics using quantitative parameters derived from hepatobiliary phase MR images.

作者信息

Ye Zheng, Cao Likun, Wei Yi, Chen Jie, Zhang Zhen, Yao Shan, Duan Ting, Song Bin

机构信息

West China School of Medicine, Sichuan University, Chengdu 610041, China.

Department of Radiology, Peking Union Medical College Hospital (Dongdan Campus), Beijing 100730, China.

出版信息

Ann Transl Med. 2020 Feb;8(4):85. doi: 10.21037/atm.2020.01.04.

DOI:10.21037/atm.2020.01.04
PMID:32175378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7049034/
Abstract

BACKGROUND

To prospectively determine whether the quantitative imaging parameters derived from the hepatobiliary phase (HBP) can be used for the preoperative prediction of hepatocellular carcinoma (HCC) with highly aggressive characteristics.

METHODS

One hundred and three patients with surgical-proven HCC were included from July 2015 to June 2018. Two independent reviewers measured signal intensity (SI) of liver and tumor, and quantitative parameters, including relative tumor enhancement (RTE), tumor to liver contrast ratio (TLR), tumor enhancement index (TEI), and relative enhancement ratio (RER) were calculated. The aggressive characteristics of HCC were identified by using the Ki-67 labeling index (LI), and patients were classified into low aggressive (Ki-67 LI ≤10%) and high aggressive (Ki-67 LI >10%) groups. The difference of quantitative parameters between two groups was assessed, and the correlation between quantitative parameters and Ki-67 LI was explored. Receiver operating characteristic analyses was used to evaluate the predictive performance of quantitative parameters.

RESULTS

The values of RTE, TLR, TEI, and RER, were significantly lower in the highly aggressive group than low aggressive group (P<0.05), and negative correlations were obtained between these quantitative parameters and Ki-67 LI ( ranges from -0.41 to -0.22, P<0.05). TLR demonstrated the highest predictive performance with the area under curve (AUC) of 0.83 [95% confidence interval (CI): 0.75-0.90], sensitivity of 89.0% and specificity of 63.3%, and subsequent with RER, TEI, and RTE with AUC of 0.78 (95% CI: 0.68-0.85), 0.74 (95% CI: 0.64-0.82) and 0.68 (95% CI: 0.58-0.77), respectively. Good inter-observer and intra-observer agreement were found in all parameters.

CONCLUSIONS

TLR showed the highest predictive performance in highly aggressive HCC. Quantitative parameters based on HBP could preoperatively predict the aggressiveness of HCC.

摘要

背景

前瞻性地确定源自肝胆期(HBP)的定量成像参数是否可用于术前预测具有高度侵袭性特征的肝细胞癌(HCC)。

方法

纳入2015年7月至2018年6月期间103例经手术证实的HCC患者。两名独立的评估者测量肝脏和肿瘤的信号强度(SI),并计算包括相对肿瘤强化(RTE)、肿瘤与肝脏对比率(TLR)、肿瘤强化指数(TEI)和相对强化率(RER)在内的定量参数。通过Ki-67标记指数(LI)确定HCC的侵袭性特征,并将患者分为低侵袭性(Ki-67 LI≤10%)和高侵袭性(Ki-67 LI>10%)组。评估两组之间定量参数的差异,并探讨定量参数与Ki-67 LI之间的相关性。采用受试者工作特征分析来评估定量参数的预测性能。

结果

高侵袭性组的RTE、TLR、TEI和RER值显著低于低侵袭性组(P<0.05),并且这些定量参数与Ki-67 LI之间存在负相关(范围从-0.41至-0.22,P<0.05)。TLR表现出最高的预测性能,曲线下面积(AUC)为0.83[95%置信区间(CI):0.75-0.90],灵敏度为89.0%,特异性为63.3%,随后是RER、TEI和RTE,AUC分别为0.78(95%CI:0.68-0.85)、0.74(95%CI:0.64-0.82)和0.68(95%CI:0.58-0.77)。所有参数在观察者间和观察者内均具有良好的一致性。

结论

TLR在高度侵袭性HCC中表现出最高的预测性能。基于HBP的定量参数可在术前预测HCC的侵袭性。

相似文献

1
Preoperative prediction of hepatocellular carcinoma with highly aggressive characteristics using quantitative parameters derived from hepatobiliary phase MR images.利用肝胆期磁共振图像衍生的定量参数对具有高度侵袭性特征的肝细胞癌进行术前预测。
Ann Transl Med. 2020 Feb;8(4):85. doi: 10.21037/atm.2020.01.04.
2
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.肝胆磁共振对比剂摄取作为预测病理侵袭性特征和降低可切除肝细胞癌无复发生存率的生物标志物:与双示踪剂 18F-FDG 和 18F-FCH PET/CT 的比较。
Eur Radiol. 2020 Oct;30(10):5348-5357. doi: 10.1007/s00330-020-06923-5. Epub 2020 May 13.
3
Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.钆塞酸增强肝脏磁共振成像在检测 HCC 和根据米兰标准和 UNOS 指南分配肝移植受者中的诊断性能:与组织病理学发现的相关性。
Radiology. 2015 Jan;274(1):149-60. doi: 10.1148/radiol.14140141. Epub 2014 Sep 5.
4
[The predictive value of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced MRI imaging features combined with quantitative parameters for the pathologic grading of hepatocellular carcinoma].钆喷酸葡胺增强磁共振成像特征联合定量参数对肝细胞癌病理分级的预测价值
Zhonghua Yi Xue Za Zhi. 2020 May 5;100(17):1299-1304. doi: 10.3760/cma.j.cn112137-20191021-02281.
5
Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.钆塞酸二钠增强 MRI 的放射组学分析预测肝细胞癌的 Ki-67 表达。
BMC Med Imaging. 2021 Jun 15;21(1):100. doi: 10.1186/s12880-021-00633-0.
6
Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.钆塞酸增强及弥散加权磁共振成像在识别细胞角蛋白 19 阳性肝细胞癌中的影像学特征:一项回顾性观察研究。
Radiology. 2018 Mar;286(3):897-908. doi: 10.1148/radiol.2017162846. Epub 2017 Nov 21.
7
Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index.肝细胞癌的全肿瘤 MRI 直方图分析:与 Ki-67 标记指数的相关性。
J Magn Reson Imaging. 2017 Aug;46(2):383-392. doi: 10.1002/jmri.25555. Epub 2016 Nov 10.
8
Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma.钆塞酸增强磁共振成像联合T1映射及临床因素预测肝细胞癌的Ki-67表达
Front Oncol. 2023 Jun 30;13:1134646. doi: 10.3389/fonc.2023.1134646. eCollection 2023.
9
Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation.良、中度肝细胞癌的影像学标志物:术前磁共振成像与组织病理学相关性。
BMC Cancer. 2019 Apr 18;19(1):364. doi: 10.1186/s12885-019-5574-8.
10
Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.小肝癌(≤1cm):钆塞酸增强磁共振成像的诊断性能和影像学特征。
Radiology. 2014 Jun;271(3):748-60. doi: 10.1148/radiol.14131996. Epub 2014 Feb 1.

引用本文的文献

1
Associations between the SMARS score derived from CT and MRI with histopathological features in HCC.基于CT和MRI得出的SMARS评分与肝癌组织病理学特征之间的关联。
Sci Rep. 2025 Jul 10;15(1):24862. doi: 10.1038/s41598-025-09918-8.
2
Associations between dynamic-contrast enhanced MRI with histopathological features in atypical HCC using spatial co-registration with biopsy.使用活检的空间共配准技术,研究非典型肝癌动态对比增强磁共振成像与组织病理学特征之间的关联。
Am J Transl Res. 2025 Apr 15;17(4):2967-2975. doi: 10.62347/PJYE7877. eCollection 2025.
3
Histogram analysis of multiple mathematical diffusion-weighted imaging models for preoperative prediction of Ki-67 expression in hepatocellular carcinoma.多种数学扩散加权成像模型对肝细胞癌术前Ki-67表达预测的直方图分析
Front Oncol. 2025 Mar 11;15:1531236. doi: 10.3389/fonc.2025.1531236. eCollection 2025.
4
Radiomics analysis of R2* maps to predict early recurrence of single hepatocellular carcinoma after hepatectomy.基于R2*图的影像组学分析预测肝细胞癌肝切除术后早期复发
Front Oncol. 2024 Feb 23;14:1277698. doi: 10.3389/fonc.2024.1277698. eCollection 2024.
5
A gadoxetic acid-enhanced MRI-based model using LI-RADS v2018 features for preoperatively predicting Ki-67 expression in hepatocellular carcinoma.一种基于钆塞酸增强MRI的模型,使用LI-RADS v2018特征术前预测肝细胞癌中Ki-67的表达。
BMC Med Imaging. 2024 Jan 25;24(1):27. doi: 10.1186/s12880-024-01204-9.
6
Diagnostic value of radiomics in predicting Ki-67 and cytokeratin 19 expression in hepatocellular carcinoma: a systematic review and meta-analysis.放射组学在预测肝细胞癌中Ki-67和细胞角蛋白19表达的诊断价值:一项系统评价和荟萃分析
Front Oncol. 2024 Jan 3;13:1323534. doi: 10.3389/fonc.2023.1323534. eCollection 2023.
7
Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma.钆塞酸增强磁共振成像联合T1映射及临床因素预测肝细胞癌的Ki-67表达
Front Oncol. 2023 Jun 30;13:1134646. doi: 10.3389/fonc.2023.1134646. eCollection 2023.
8
A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy.纳入组织病理学和术前钆塞酸增强 MRI 的模型预测根治性肝切除术后无微血管侵犯的肝细胞癌早期复发。
Br J Radiol. 2023 Mar 1;96(1144):20220739. doi: 10.1259/bjr.20220739. Epub 2023 Mar 6.
9
Preoperative radiomics model using gadobenate dimeglumine-enhanced magnetic resonance imaging for predicting β-catenin mutation in patients with hepatocellular carcinoma: A retrospective study.使用钆喷酸葡胺增强磁共振成像的术前放射组学模型预测肝细胞癌患者β-连环蛋白突变:一项回顾性研究
Front Oncol. 2022 Sep 16;12:916126. doi: 10.3389/fonc.2022.916126. eCollection 2022.
10
Prediction of Histological Grades and Ki-67 Expression of Hepatocellular Carcinoma Based on Sonazoid Contrast Enhanced Ultrasound Radiomics Signatures.基于索拉非尼对比增强超声放射组学特征预测肝细胞癌的组织学分级和Ki-67表达
Diagnostics (Basel). 2022 Sep 8;12(9):2175. doi: 10.3390/diagnostics12092175.

本文引用的文献

1
Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study.钆塞酸增强磁共振成像纹理分析预测肝细胞癌Ki-67状态的前瞻性研究
Chin J Cancer Res. 2019 Oct;31(5):806-817. doi: 10.21147/j.issn.1000-9604.2019.05.10.
2
Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.基于钆塞酸增强 MRI 的祖细胞表型无创预测 HCC。
Eur Radiol. 2020 Feb;30(2):1232-1242. doi: 10.1007/s00330-019-06414-2. Epub 2019 Sep 16.
3
Texture analysis of multi-phase MRI images to detect expression of Ki67 in hepatocellular carcinoma.多相 MRI 图像纹理分析检测肝细胞癌中 Ki67 的表达。
Clin Radiol. 2019 Oct;74(10):813.e19-813.e27. doi: 10.1016/j.crad.2019.06.024. Epub 2019 Jul 27.
4
Small hepatocellular carcinoma: using MRI to predict histological grade and Ki-67 expression.小肝细胞癌:利用 MRI 预测组织学分级和 Ki-67 表达。
Clin Radiol. 2019 Aug;74(8):653.e1-653.e9. doi: 10.1016/j.crad.2019.05.009. Epub 2019 Jun 11.
5
Diffusion kurtosis imaging (DKI) of hepatocellular carcinoma: correlation with microvascular invasion and histologic grade.肝细胞癌的扩散峰度成像(DKI):与微血管侵犯及组织学分级的相关性
Quant Imaging Med Surg. 2019 Apr;9(4):590-602. doi: 10.21037/qims.2019.02.14.
6
Local modalities for inoperable hepatocellular carcinoma: radiofrequency ablation versus stereotactic body radiotherapy.不可切除肝细胞癌的局部治疗方式:射频消融与立体定向体部放疗
Ann Transl Med. 2018 Nov;6(Suppl 1):S3. doi: 10.21037/atm.2018.08.28.
7
Effect of KI-67 positive cellular index on prognosis after hepatectomy in Barcelona Clinic Liver Cancer stage A and B hepatocellular carcinoma with microvascular invasion.KI-67阳性细胞指数对巴塞罗那临床肝癌分期A和B期伴微血管侵犯的肝细胞癌肝切除术后预后的影响。
Onco Targets Ther. 2018 Aug 10;11:4747-4754. doi: 10.2147/OTT.S165244. eCollection 2018.
8
Association between relative liver enhancement on gadoxetic acid enhanced magnetic resonance images and histologic grade of hepatocellular carcinoma.钆塞酸二钠增强磁共振图像上肝脏相对强化与肝细胞癌组织学分级之间的关联
Medicine (Baltimore). 2017 Jul;96(30):e7580. doi: 10.1097/MD.0000000000007580.
9
DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma.DNA拓扑异构酶IIα和Ki67是肝细胞癌患者的预后因素。
Oncol Lett. 2017 Jun;13(6):4109-4116. doi: 10.3892/ol.2017.5999. Epub 2017 Apr 6.
10
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.肝细胞癌的组织学亚型与基因突变和分子肿瘤分类有关。
J Hepatol. 2017 Oct;67(4):727-738. doi: 10.1016/j.jhep.2017.05.014. Epub 2017 May 19.